- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ER+ and AR+ Breast Cancer in Australia
Total 1702 results
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
Hoffmann-La RocheTerminated
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Trans Tasman Radiation Oncology Group3MCompleted
-
Barwon HealthUnknown
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal Cancer, Gastric CancerAustria
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States, Australia
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Medical University of ViennaDaiichi Sankyo, Inc.Recruiting
-
ETOP IBCSG Partners FoundationCompleted
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
PureTechNovotech (Australia) Pty LimitedTerminatedLymphoedema | Breast Cancer Related LymphoedemaUnited States, Australia
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
-
IpsenTerminated
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Medical University of GrazActive, not recruiting
-
Medical University of ViennaUniversity of Natural Resources and Life Sciences, Vienna, AustriaCompleted
-
Hoffmann-La RocheCompleted
-
Olema Pharmaceuticals, Inc.Active, not recruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States, Australia
-
PfizerCompletedBreast CancerAustralia, India
-
Johannes Kepler University of LinzCharles University, Czech Republic; Charite University, Berlin, Germany; German... and other collaboratorsRecruiting
-
Hoffmann-La RocheCompleted
-
Siemens Healthcare QTMedical University of ViennaCompletedBreast Cancer DiagnosisAustria
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AGCompleted
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, New Zealand, Hong Kong
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Medical University of GrazWithdrawnBreast Cancer | Radiotherapy Side EffectAustria
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom, Spain, Australia, Sweden
-
University of SydneyCompletedBreast CancerAustralia
-
German Breast GroupRecruiting
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Medical University of ViennaUnknownGd-based Contrast Media Exposure During Breast MRI ScansAustria
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Hoffmann-La RocheTerminated
-
CelgeneCompleted
-
Medical University of ViennaDaiichi Sankyo, Inc.CompletedBreast Cancer Stage IVAustria
-
Karolinska InstitutetRecruitingBreast CancerSweden, Finland, Australia, United Kingdom
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
University of Erlangen-Nürnberg Medical SchoolCompletedBreast CancerGermany, Austria
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia